Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Westrick

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Thrombosis and Haemostasis : JTH|July 28, 2009
Modifier genes for disorders of thrombosis and hemostasisR J Westrick, D Ginsburg
Blood Advances|November 8, 2019
Thrombus stability explains the factor V Leiden paradox: a mouse modelS A Shaya, R J Westrick, P L Gross
Blood|January 11, 2000
Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in miceD T Eitzman, R J Westrick, E G Nabel, et al.
Thrombosis and Haemostasis|April 20, 2001
Pulmonary fibrosis is increased in mice carrying the factor V Leiden mutation following bleomycin injuryZ Xu, R J Westrick, Y C Shen, et al.
Genomics|November 10, 1998
Comparative mapping of distal murine chromosome 11 and human 17q21.3 in a region containing a modifying locus for murine plasma von Willebrand factor levelK L Mohlke, A A Purkayastha, R J Westrick, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 15, 2000
Hyperlipidemia promotes thrombosis after injury to atherosclerotic vessels in apolipoprotein E-deficient miceD T Eitzman, R J Westrick, Z Xu, et al.
Blood|December 9, 2000
Plasminogen activator inhibitor-1 deficiency protects against atherosclerosis progression in the mouse carotid arteryD T Eitzman, R J Westrick, Z Xu, et al.
Circulation|June 27, 2001
Deficiency of tissue factor pathway inhibitor promotes atherosclerosis and thrombosis in miceR J Westrick, P F Bodary, Z Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 1999
The plasminogen activator inhibitor-2 gene is not required for normal murine development or survivalK M Dougherty, J M Pearson, A Y Yang, et al.
Cell|February 16, 1999
Mvwf, a dominant modifier of murine von Willebrand factor, results from altered lineage-specific expression of a glycosyltransferaseK L Mohlke, A A Purkayastha, R J Westrick, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Thrombosis and Haemostasis : JTH|July 28, 2009
Modifier genes for disorders of thrombosis and hemostasisR J Westrick, D Ginsburg
Blood Advances|November 8, 2019
Thrombus stability explains the factor V Leiden paradox: a mouse modelS A Shaya, R J Westrick, P L Gross
Blood|January 11, 2000
Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in miceD T Eitzman, R J Westrick, E G Nabel, et al.
Thrombosis and Haemostasis|April 20, 2001
Pulmonary fibrosis is increased in mice carrying the factor V Leiden mutation following bleomycin injuryZ Xu, R J Westrick, Y C Shen, et al.
Genomics|November 10, 1998
Comparative mapping of distal murine chromosome 11 and human 17q21.3 in a region containing a modifying locus for murine plasma von Willebrand factor levelK L Mohlke, A A Purkayastha, R J Westrick, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 15, 2000
Hyperlipidemia promotes thrombosis after injury to atherosclerotic vessels in apolipoprotein E-deficient miceD T Eitzman, R J Westrick, Z Xu, et al.
Blood|December 9, 2000
Plasminogen activator inhibitor-1 deficiency protects against atherosclerosis progression in the mouse carotid arteryD T Eitzman, R J Westrick, Z Xu, et al.
Circulation|June 27, 2001
Deficiency of tissue factor pathway inhibitor promotes atherosclerosis and thrombosis in miceR J Westrick, P F Bodary, Z Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 1999
The plasminogen activator inhibitor-2 gene is not required for normal murine development or survivalK M Dougherty, J M Pearson, A Y Yang, et al.
Cell|February 16, 1999
Mvwf, a dominant modifier of murine von Willebrand factor, results from altered lineage-specific expression of a glycosyltransferaseK L Mohlke, A A Purkayastha, R J Westrick, et al.
Pageof 2